Valeant: Still A Bad Investment [Seeking Alpha]
VALEANT PHARMACEUTICALS (VRX)
Last valeant pharmaceuticals earnings: 2/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.valeant.com
Company Research
Source: Seeking Alpha
Summary Source The market is getting irrationally exuberant about Valeant's (NYSE: VRX ) so-called turnaround story, and people are forgetting about the core erosion in the company's portfolio. Sure, debt paydown is great, but what if EBITDA falls so fast that debt pay down doesn't matter? Valeant is convincingly addressing the debt issue, but the company is very far away from turning around. Lack of Growth Drivers Valeant has traditionally neglected its R&D budget, and it shows. Many of Valeant's core assets are eroding, and this is not necessarily because of fallout from the loss of Philidor or loss of pricing power because of increased regulatory scrutiny. No, the problem with Valeant is a lack of growth drivers. For most pharma companies, loss of exclusivities (LOE) and generic erosion aren't a big deal because old drugs are constantly being replaced by new ones. But in Valeant's case, the growth drivers simply are too weak to make up for the losses i
Show less
Read more
Impact Snapshot
Event Time:
VRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRX alerts
High impacting VALEANT PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics